tiprankstipranks
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Balance Sheet

276 Followers

Summit Therapeutics Balance Sheet

Summit Therapeutics's total assets for Q4 2023 were $202.95M, a decrease of -7.11% from the previous quarter. SMMT total liabilities were $125.26M for the fiscal quarter, a 5.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 202.95M$ 664.17M$ 113.37M$ 102.50M$ 73.12M
Total Liabilities
$ 125.26M$ 537.51M$ 30.09M$ 23.05M$ 13.90M
Total Equity Gross Minority
$ 77.69M$ 126.65M$ 83.28M$ 79.45M$ 59.23M
Total Capitalization
$ 280.98M$ 621.19M$ 83.28M$ 79.45M$ 59.23M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 465.00K$ 678.00K
Currency in USD

Summit Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis